2-Methylthio-2-thiazoline is used as a reagent in the synthesis of new thiazole derivatives including a guanidine group, which can be used as human vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.